Systemic blockade of ACVR2B ligands prevents chemotherapy-induced muscle wasting by restoring muscle protein synthesis without affecting oxidative capacity or atrogenes

T. A. Nissinen, J. Degerman, M. Räsänen, A. R. Poikonen, S. Koskinen, E. Mervaala, A. Pasternack, O. Ritvos, R. Kivela, J. J. Hulmi

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number32695
JournalScientific Reports
Volume6
Number of pages16
ISSN2045-2322
DOIs
Publication statusPublished - 26 Sep 2016
MoE publication typeA1 Journal article-refereed

Fields of Science

  • ACUTE DOXORUBICIN CARDIOTOXICITY
  • SKELETAL-MUSCLE
  • EXERCISE PROTECTS
  • CANCER CACHEXIA
  • MDX MICE
  • EXPRESSION
  • MYOSTATIN
  • RECEPTOR
  • HEART
  • CARDIOMYOPATHY
  • 3111 Biomedicine

Cite this